Jefferies Financial Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-45,000
Closed -$2.5M – 1995
2025
Q3
$2.5M Buy
+45,000
New +$2.63M 0.01% 567
2024
Q4
– Sell
-10,800
Closed -$1.29M – 1762
2024
Q3
$1.29M Buy
+10,800
New +$1.44M 0.01% 716
2024
Q2
– Sell
-10,000
Closed -$1.28M – 1749
2024
Q1
$1.28M Buy
+10,000
New +$1.19M 0.01% 732

Other funds holding NVO

Jefferies Financial Group's NVO Position: Q2 2026 in Review

Jefferies Financial Group sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 16,524 shares — an estimated $607K sold.

Jefferies Financial Group first reported a position in NVO in Q4 2022 and held it in 14 quarters. The position peaked at $2.29M in Q3 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Jefferies Financial Group reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
  • Jefferies Financial Group sold 16,524 Novo Nordisk shares in Q2 2026, an estimated $607K.
  • Jefferies Financial Group first reported a position in Novo Nordisk in Q4 2022 and held it in 14 quarters.
  • Jefferies Financial Group's Novo Nordisk position peaked at $2.29M in Q3 2024.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.